Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-041405
Filing Date
2021-02-12
Accepted
2021-02-12 16:00:58
Documents
1
Group Members
JOHN S. CLARK IISOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP, LLCSOUTHPOINT GP, LPSOUTHPOINT MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d111041dsc13ga.htm SC 13G/A 132626
  Complete submission text file 0001193125-21-041405.txt   134631
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80470 | Film No.: 21626981
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1114 AVENUE OF THE AMERICAS 22ND FLOOR NEW YORK NY 10036
Business Address 1114 AVENUE OF THE AMERICAS 22ND FLOOR NEW YORK NY 10036 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

EIN.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A